Introduction

China has tightened export controls on 18 drug-making chemicals shipped to North America, requiring permits ahead of a pivotal Xi-Trump summit. The move escalates enforcement against chemicals used in fentanyl and methamphetamine production.

What Happened

Beijing announced new permit requirements for two additional chemicals, bringing the total under restriction to 18. The restrictions cover exports to the United States, Mexico, and Canada, following years of U.S. pressure over the flow of precursor chemicals into illicit drug labs.

Why This Matters

The policy shift comes days before President Xi Jinping meets with former President Donald Trump at the White House, highlighting how chemical regulation has become a central point in U.S.-China relations. Previous rounds of controls in late 2025 and earlier this year already targeted 16 other substances, with U.S. officials urging Beijing to treat the crisis as a priority.

Key Takeaways

  • China now requires permits for 18 categories of chemicals linked to illegal drug manufacturing.
  • The restrictions apply to shipments destined for the U.S., Mexico, and Canada.
  • The timing aligns with a high-level diplomatic meeting, signaling enforcement may influence broader negotiations.
  • Earlier controls in November 2025 and May 2025 already targeted 16 other precursor chemicals.
  • U.S. officials have long identified China as the primary source of many fentanyl-related precursors.

Conclusion

As the Xi-Trump meeting approaches, these expanded chemical controls underscore how drug enforcement has become intertwined with diplomatic strategy. Whether the measures will significantly curb illicit synthetic drug flows remains to be seen, but they signal a sustained push from Washington to hold Beijing accountable on precursor oversight.